BIO Launches New Video Explaining How The Cost of Your Medicine is Really Determined

From our partners at the Biotechnology Innovation Organization (BIO)

By Jim Greenwood, President & CEO, BIO
Oct. 26, 2016 | View More

Today, much of the public debate surrounding the cost of biopharmaceuticals is focused on the list price of an individual drug or treatment regimen.

However, the list price is not what a manufacturer generally makes on the drug, and it typically has little to do with what a patient has to pay for his or her medicine.

To help put this debate into context, the Biotechnology Innovation Organization (BIO) is releasing a new educational video today designed to give patients, consumers, policy makers and journalists a better understanding of how prescription drug costs are really determined and where the pharmaceutical dollar actually goes.

Read the full blog post from BIO Pres. & CEO Jim Greenwood here.